The dispositions that regulate generic substitution in Switzerland have been recently
revised, and impose definite incentives on prescribers. The benefits and drawbacks …

Generic or non-proprietary drugs play an increasing part in the French pharmaceutical
market. These copies of the original brand name medicines are available once drug patents …

Background Generic substitution of drugs was introduced in Norway in 2001. This implies an
obligation for pharmacies to substitute the prescribed drug with a generic equivalent. Instead …

Compared with other countries with a similar socio-economic environment, generic drugs
account for a very small proportion of pharmaceutical sales in France. The recently …

Background Since generic drugs have the same therapeutic effect as the original
formulation but at generally lower costs, their use should be more heavily promoted …

REIMBURSABLE DRUGS: The reimbursement, or coverage of pharmaceutical costs by the
sickness benefits is governed in the French system by two conditions: the drugs must have …

A generic medicine is a faithful copy of a mature drug—no longer under patent—marketed
with the chemical name of the active ingredient. This article analyses generics markets in …

Purpose The aim of the present study was to investigate obstacles to generic substitution
and savings achieved during the first year after Sweden introduced generic substitution in …

Objective: In 1999, a new law was introduced, giving French pharmacists the right to switch
from branded to generic drugs, unless the prescriber had specified that substitution was not …

The term “generic drug” designates any drug “which has the same qualitative and
quantitative composition of active substances, and the same pharmaceutical form, and …